Medtronic to acquire CathWorks at a valuation of $585m.

Medtronic, a medical device company, agreed to acquire CathWorks, a digital health technology company, at a valuation of $585m. "We are thrilled to have CathWorks officially become part of the Medtronic family. Our successful co-promotion over the past three years has unlocked significant opportunities in the coronary physiology market through the expanded utilization of our innovative technology. With Medtronic's vast global footprint, FFRangio will continue to reach even more patients globally. Bringing Medtronic and CathWorks together will create a best-in-class organization focused on driving new standards of care to transform the cath lab," Ramin Mousavi, CathWorks President and Chief Executive Officer.